Literature DB >> 7955467

Antibodies to proteins from Pityrosporum ovale in the sera from patients with psoriasis.

L Squiquera1, R Galimberti, L Morelli, L Plotkin, R Milicich, A Kowalckzuk, J Leoni.   

Abstract

In order to analyse the humoral immune response to the commensal yeast Pityrosporum ovale, we developed a western immunoblot technique with a salt soluble extract of P. ovale cytoplasm. In the present study, we tested sera from patients with psoriasis (n = 15), seborrhoeic dermatitis (n = 10), pityriasis versicolor (n = 8), and normal controls (n = 10). Seventy-three per cent (11/15) of the patients with psoriasis showed specific reactivity with a protein derived from P. ovale of estimated molecular mass 120 kDa, and 46% (7/15) of the cases recognized a 100-kDa protein. Sera from pityriasis versicolor and normal donors showed nonspecific reactivity with several bands of lower molecular weight. To characterize the location of the 100 and 120-kDa proteins, we performed a lyticase digestion of the cell wall, and analysed the soluble digested products by western blotting. The sera from psoriasis patients detected several bands in the range 100-120 kDa. The finding of the immunoreactive 120-kDa protein in this fraction suggests its location at the space between cell wall and membrane (periplasmic space). As a control, we performed an extraction of the cytoplasmic proteins of the dimorphic yeast Candida albicans. C. albicans showed a different pattern of banding in SDS-PAGE. Immunoblots with C. albicans did not allow the detection of any related band. A smear was observed in the high molecular weight range consistent with the presence of lipopolysaccharides. The role of the immune response in infection by P. ovale has not yet been fully explored.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7955467     DOI: 10.1111/j.1365-2230.1994.tb01197.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  9 in total

1.  Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions.

Authors:  Luciana C Paulino; Chi-Hong Tseng; Bruce E Strober; Martin J Blaser
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

2.  Protein profiles of Malassezia pachydermatis isolated from dogs.

Authors:  S D Coutinho; T de Souza; C R Paula
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

Review 3.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  Humoral immune response to Malassezia furfur in patients with pityriasis versicolor and seborrheic dermatitis.

Authors:  V Silva; O Fischman; Z P de Camargo
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

5.  The Role of Fungi in the Etiology of Multiple Sclerosis.

Authors:  Julián Benito-León; Martin Laurence
Journal:  Front Neurol       Date:  2017-10-16       Impact factor: 4.003

6.  Spondyloarthritis, Acute Anterior Uveitis, and Fungi: Updating the Catterall-King Hypothesis.

Authors:  Martin Laurence; Mark Asquith; James T Rosenbaum
Journal:  Front Med (Lausanne)       Date:  2018-04-05

7.  Malassezia and Parkinson's Disease.

Authors:  Martin Laurence; Julián Benito-León; Frédéric Calon
Journal:  Front Neurol       Date:  2019-07-24       Impact factor: 4.003

8.  Interplay between Humoral and CLA+ T Cell Response against Candida albicans in Psoriasis.

Authors:  Carmen de Jesús-Gil; Lídia Sans-de San Nicolàs; Ester Ruiz-Romeu; Marta Ferran; Laura Soria-Martínez; Irene García-Jiménez; Anca Chiriac; Josep Manel Casanova-Seuma; Josep Manel Fernández-Armenteros; Sherry Owens; Antonio Celada; Michael D Howell; Ramòn María Pujol; Luis Francisco Santamaria-Babí
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

Review 9.  Cutaneous Malassezia: Commensal, Pathogen, or Protector?

Authors:  Shree Harsha Vijaya Chandra; Ramasamy Srinivas; Thomas L Dawson; John E Common
Journal:  Front Cell Infect Microbiol       Date:  2021-01-26       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.